Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines

Carcinogenesis

Volumn 20, Issue 11, 1999, Pages 2063-2073

  Gupta, Ashok ^a   Rosenberger, Sabine F ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYCLIC AMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLNITRONITROSOGUANIDINE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; IONIZING RADIATION; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PHENOTYPE; PRIORITY JOURNAL; RADIATION; TRANSACTIVATION; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; CELL LINE, TRANSFORMED; ENZYME ACTIVATION; KERATINOCYTES; METHYLNITRONITROSOGUANIDINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0032722406     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.11.2063     Document Type: Article

References (76)

1. Hennings, H., Shores, R., Weick, M.L., Spangler, E.F., Tarone, R. and Yuspa, S.H. (1983) Malignant conversion of mouse skin tumors is increased by tumor initiators and unaffected by tumor promoters. Nature, 304, 67-69.
2. Boutwell, R.K. (1974) The function and mechanism of promoters of carcinogenesis. C. R. Crit. Rev. Toxicol., 2, 419-443.
3. Finch, J.S. and Bowden, G.T. (1996) PCR/RFLP assay for copy number of mutant and wild-type alleles. Biotechniques, 21, 1055-1060.
4. DiGiovanni, J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128.
5. Dong, Z., Birrer, M.J., Watts, R.G., Matrisian, L.M. and Colburn, N.H. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA, 91, 609-613.
6. Domann, F.E.Jr, Levy, J.P., Finch, J.S. and Bowden, G.T. (1994) Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog., 9, 61-66.
7. Li, J.J., Dong, Z., Dawson, M.I. and Colburn, N.H. (1996) Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res., 56, 483-489.
8. Dong, Z., Crawford, H.C., Lavrovsky, V., Taub, D., Watts, R., Matrisian, L.M. and Colburn, N.H. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog., 19, 204-212.
9. Karin, M., Liu, Z.G. and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol., 9, 240-246.
10. Watts, R.G., Ben-Ari, E.T., Bernstein, L.R., Birrer, M.J., Winterstein, D., Wendel, E. and Colburn, N.H. (1995) c-jun and multistage carcinogenesis, association of overexpression of introduced c-jun with progression toward a neoplastic endpoint in mouse JB6 cells sensitive to tumor promoter-induced transformation. Mol. Carcinog., 13, 27-36.
11. Domann, F.E., Levy, J.P., Birrer, M.J. and Bowden, G.T. (1994) Stable expression of a c-Jun deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ., 5, 9-16.
12. Bernstein, L.R. and Colburn, N.H. (1989) AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244, 566-569.
13. Rosenberger, S.F. and Bowden, G.T. (1996) Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression. Oncogene, 12, 2301-2308.
14. Baeuerle, P.A. and Baltimore, D. (1996) NF-kappaB: ten years after. Cell, 87, 13-20.
15. Li, J.J., Westergaard, C., Ghosh, P. and Colburn, N.H. (1997) Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res., 57, 3569-3576.
16. Li, J.J., Rhim, J.S., Schlegel, R., Vousden, K.H. and Colburn, N.H. (1998) Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene, 16, 2711-2721.
17. Saran, M., Michel, C. and Bors, W. (1998) Radical functions in vivo. A critical review of current concepts and hypotheses. Z Naturforch., 53c, 210-227.
18. Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M.G. and Packer, L. (1997) Redox regulation of NF-kappa B activation. Free Radic. Biol. Med., 22, 1115-1126.
19. Abate, C., Patel, L., Rauscher, F.J.III and Curran, T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro, Science, 249, 1157-1161.
20. Amstad, P.A., Krupitza, G. and Cerutti, P.A. (1992) Mechanism of c-fos induction by active oxygen. Cancer Res., 52, 3952-3960.
21. Su, B. and Karin, M. (1996) Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol., 8, 402-411.
22. Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J. and Greenberg, M.E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 270, 1326-1331.
23. Wang, X., Martindale, J.L., Liu, Y. and Holbrook, N.J. (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J., 333, 291-300.
24. Karin, M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270, 16483-16486.
25. Lee, F.S., Hagler, J., Chen, Z.J. and Maniatis, T. (1997) Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell, 88, 213-222.
26. Schwenger, P., Alpert, D., Skolnik, E.Y. and Vilcek, J. (1998) Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol. Cell. Biol., 18, 78-84.
27. 2. Role in cell survival following oxidant injury. J. Biol. Chem., 271, 4138-4142.
28. Wilmer, W.A., Tan, L.C., Dickerson, J.A., Danne, M. and Rovin, B.H. (1997) Interleukin-1beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J. Biol. Chem., 272, 10877-10881.
29. Cerutti, P. (1988) Oxidant tumor promoters. In Colburn, N.H., Moses, H. and Stanbridge, E.J. (eds) Growth Factors, Tumor Promoters and Cancer Genes. Alan R. Liss, New York, NY, pp. 239-247.
30. Oberley, L. and Oberley, T. (1986) Free radicals cancer and aging. In Johnson, J.E., Walford, R.Jr, Harman, D. and Miguel, J. (eds) Free radicals, Aging and Degenerative Diseases. Alan R. Liss, New York, NY, pp. 325-371.
31. Palozza, P., Agostara, G., Piccioni, E. and Bartoli, G.M. (1994) Different role of lipid peroxidation in oxidative stress-induced lethal injury in normal and tumor thymocytes. Arch. Biochem. Biophys., 312, 88-94.
32. Loeb, L., James, E., Waltersdorph, A., Stokes, K. and Klebanoff, S. (1988) Mutagenisis by oxygen free radicals in vitro. Proc. Am. Assoc. Cancer Res., 28, 162-168.
33. Troll, W. and Wiesner, R. (1985) The role of oxygen radicals as a possible mechanism of tumor promotion. Annu. Rev. Pharmacol. Toxicol., 25, 509-528.
34. Cerutti, P. (1986) The role of active oxygen in tumor promotion. In Harris, C. (ed.) Biochemical and Molecular Epidemiology of Cancer. Alan R. Liss, New York, NY, pp. 167-176.
35. Kennedy, A., Troll, W. and Little, J. (1984) Role of free radicals in the initiation and promotion of radiation transformation in vitro. Carcinogenesis, 5, 1213-1218.
36. Amstad, P., Liu, H., Ichimiya, M., Berezesky, I.K. and Trump, B.F. (1997) Manganese superoxide dismutase inhibits soft agar growth in JB6 clone 41 mouse epidermal cells. Carcinogenesis, 18, 479-484.
37. Troll, W., Frenkel, K. and Teebor, G. (1983) Free oxygen radicals. Necessary contributions to tumor promotion and cocarcinogenesis. In Fujiki, H. (ed) Cellular Interactions by Environmental Tumor Promoters. VNU Science Press, Utrecht, The Netherlands, pp. 207-210.
38. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearson, E.R., Sundaresan, M., Finkel, T. and Goldschmidt-Clermont, P.J. (1997) Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science, 275, 1649-1652.
39. Yuspa, S.H. (1998) The pathogenesis of squamous cell cancer: lessons learned from studies of skin Carcinogenesis. J. Dermatol. Sci., 17, 1-7.
40. Ananthaswamy, H.N. and Pierceall, W.E. (1990) Molecular mechanisms of ultraviolet radiation Carcinogenesis. Photochem. Photobiol., 52, 1119-1136.
41. Strickland, J.E., Greenhalgh, D.A., Koceva-Chyla, A., Hennings, H., Restrepo, C., Balaschak, M. and Yuspa, S.H. (1988) Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res., 48, 165-169.
42. Gupta, A., Andrews, K.L., McDaniel, K.M., Nagle, R.B. and Bowden, G.T. (1999) Experimental induction of rhabdomyosarcoma in mice with fractionated doses of β-irradiation. J. Cancer Res. Clin. Oncol., 125, 257-267.
43. Galien R., Emanoil-Ravier, R. and Mercier, G. (1994) Differential effects of c-jun and CREB on c-AMP response activation by Ha-ras. Oncogene, 9, 1101-1108.
44. Rosenberger, S.F., Finch, J.S., Gupta, A. and Bowden, G.T. (1999) Extracellular signal regulated kinase (ERK) 1/2 mediated phosphorylation of JunD and FosB is required for okadaic acid induced AP-1 activation. J. Biol. Chem., 274, 1124-1130.
45. Game, S.M., Huelsen, A., Patel, V., Donnelly, M., Yeudall, W.A., Stone, A., Fusenig, N.E. and Prime, S.S. (1992) Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int. J. Cancer, 52, 461-470.
46. Chinery, R., Beauchamp, R.D., Shyr, Yu., Kirkland, S.C., Coffey, R.J. and Morrow, J.D. (1998) Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production and proliferation in colorectal cancer cells. Cancer Res., 58, 2323-2327.
47. Barthelman, M., Chen, W., Gensler, H.L., Huang, C., Dong, Z. and Bowden, G.T. (1998) Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res., 58, 711-716.
48. Rathakrishnan, C. and Tiku, M.L. (1993) Lucigenin-dependent chemiluminescence in articular chondrocytes. Free Radic. Biol. Med., 15, 143-149.
49. Dignam, J.D., Lebovitz, R.M. and Roeder, R.G. (1983) Accurate transcriptional initiation by RNA polymerase II in a soluble extract from isolated nuclei. Nucleic Acids Res., 11, 1475-1489.
50. Livingstone, C., Patel, G. and Jones, N. (1995) ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J., 14, 1785-1797.
51. Muehlematter, D., Larsson, R. and Cerutti, P. (1988) Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis, 9, 239-245.
52. Pang, L., Sawada, T., Decker, S.J. and Saltiel, A.R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem., 270, 13585-13588.
53. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., Strickler, J.E., McLaughlin, M.M., Siemens, I.R., Fisher, S.M., Livi, G.P., White, J.R., Adams, J.L. and Young, P.R. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-746.
54. Schmitz, M.L. and Baeuerle, P.A. (1991) The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J., 10, 3805-3817.
55. Collins, T., Read, M.A., Neish, A.S., Whitley, M.Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J., 9, 899-909.
56. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature, 376, 167-170.
57. Stein, B., Baldwin, A.S.Jr, Ballard, D.W., Greene, W.C., Angel, P. and Herrlich, P. (1993) Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J., 12, 3879-3891.
58. Baldwin, A.S.Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann. Rev. Immunol., 14, 649-683.
59. Naumann, M. and Scheidereit, C. (1994) Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J., 13, 4597-4607.
60. Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W. and Haegeman, G. (1998) p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem., 273, 3285-3290.
61. Karin, M. and Smeal, T. (1992) Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci., 17, 418-422.
62. Price, M.A., Rogers, A.E. and Treisman, R. (1995) Comparative analysis of the ternary complex factors Elk-1, SAP-1a and SAP-2 (ERP/NET). EMBO J., 14, 2589-2601.
63. Herr, I., van Dam, H. and Angel, P. (1994) Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis, 15, 1105-1113.
64. De Cesare, D., Vallone, D., Caracciolo, A., Sassone-Corsi, P., Nerlov, C. and Verde, P. (1995) Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene, 11, 365-376.
65. Bruening, W., Giasson, B., Mushynski, W. and Durham, H.D. (1998) Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter. Nucleic Acids Res., 26, 486-489.
66. Huang, C., Ma, W.Y., Young, M.R., Colburn, N. and Dong, Z. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA, 95, 156-161.
67. Cowley, S., Paterson, H., Kemp, P. and Marshall, C.J. (1994) Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell, 77, 841-852.
68. Cobb, M.H. and Goldsmith, E.J. (1995) How MAP kinases are regulated. J. Biol. Chem., 270, 14843-14846.
69. Schwenger, P., Bellosta, P., Victor, I., Basilico, C., Skolnik, E.Y. and Vilcek, J. (1997) Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc. Natl Acad. Sci. USA, 94, 2869-2873.
70. Ushio-Fukai, M., Alexander, R.W., Akers, M. and Griendling, K.K. (1998) p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J. Biol. Chem., 273, 15022-15029.
71. Cuenda, A., Cohen, P., Buee-Scherrer, V. and Goedert, M. (1997) Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J., 16, 295-305.
72. Rouse, J., Cohen, P., Trigon, S., Morange, M., Alonso-Llamazares, A., Zamanillo, D., Hunt, T. and Nebreda, A.R. (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell, 78, 1027-1037.
73. Nemoto, S., Xiang, J., Huang, S. and Lin, A. (1998) Induction of apoptosis by SB202190 through inhibition of p38 beta mitogen-activated protein kinase. J. Biol. Chem., 273, 16415-16420.
74. Wilhelm, D., Bender, K., Knebel, A and Angel, P. (1997) The level of intracellular glutathione is a key regulator for the induction of stress activated signal transduction pathways including Jun N-terminal kinases and p38 kinase by alkylating agents. Mol. Cell Biol., 17, 4792-4800.
75. 2 stimulate mitogen-activated protein kinase activity in NIH 3T3 cells through the formation of reactive oxygen intermediates. Cancer Res., 54, 12-15.
76. White, M.A., Nicolette, C., Minden, A., Polverino, A., Van Aelst, L., Karin, M. and Wigler, M.H. (1995) Multiple Ras functions can contribute to mammalian cell transformation. Cell, 80, 533-541.